AI Summary
GILD (GILD) is currently trading at $152.88, up 2.13% in the last 24 hours. We maintain a HOLD rating pending clearer directional signals.
Price
Volume
P/E Ratio
Insider
Price Chart
Price Data
Fundamentals
Technical Analysis Summary
27 indicators analyzed
Technical picture is moderately bullish with 18 buy signals vs 6 sell signals. Trend favors long positions with proper risk management.
Technical Indicators
Momentum & trend signals
💡 Technical indicators are tools, not guarantees. Always combine with fundamental analysis.
MACD
(12, 26, 9)Bollinger Bands
Volatility & breakout detection
Stochastic Oscillator
Momentum indicator (14,3,3)
📊 Neutral: GILD stochastic is in the middle range (99.0). Wait for %K to enter overbought (80+) or oversold (20-) zones for clearer signals.
Average True Range (ATR)
📌 Normal volatility conditions - standard position sizing appropriate.
On-Balance Volume (OBV)
Volume-based momentum indicator
📈 Volume confirms uptrend: OBV rising above its average suggests institutional accumulation. Bullish signal for trend continuation.
Pivot Points
Key Support & Resistance Levels
All Pivot Levels
Price is trading above the pivot point at $148.58, indicating bullish bias. Watch R1 ($151.29) as the next target.
⚠️ Wide range - higher volatility expected. Use wider stops.
Fibonacci Retracement
| Level | Price | Type | Distance |
|---|---|---|---|
| 0% | $153.13 | Current | -0.2% |
| 23.6% | $139.03 | Support | +9.0% |
| 38.2% | $130.30 | Support | +14.7% |
| 50%✦ | $123.25 | Support | +19.3% |
| 61.8%✦ | $116.20 | Support | +24.0% |
| 78.6% | $106.16 | Support | +30.5% |
| 100% | $93.37 | Support | +38.9% |
VWAP (Volume Weighted Avg Price)
Parabolic SAR
Stop and Reverse Indicator
🚀 Strong uptrend for 13 days. SAR at $139.80 acts as trailing stop. Ride the trend until SAR is hit.
Williams %R
📈 OVERBOUGHT: Williams %R at -1.1 indicates the stock is trading near its 14-day high. Strong momentum continues - may stay overbought in uptrends.
📊 CCI (Commodity Channel Index)
Momentum oscillator measuring price deviation
Strength: 50%
Previous CCI
+124.5
Typical Price
$151.60
SMA (20)
$133.99
Mean Deviation
$8.88
📈 OVERBOUGHT: CCI at 132.1 (above +100) indicates strong bullish momentum. Uptrend intact - ride the trend but watch for reversal signs.
20-Day CCI History
🎯Aroon Indicator(25-period)
📈 STRONG UPTREND: Aroon Up at 100 (above 70) with Aroon Down at 8 (below 30). Price made its 25-day high 0 day(s) ago. Trend is healthy - stay long and trail stops. Oscillator at 92.0 shows bullish bias.
📊 Rate of Change (ROC)Buy
Strong BullishUltimate Oscillator
Multi-timeframe momentum (7, 14, 28)
Keltner Channels
ATR-based volatility bands
📈 EXTENDED ABOVE CHANNEL: Price 152.81 is riding above the upper band (145.15). Strong trend - price can stay extended. Consider trailing stops rather than fading.
TTM Squeeze
John Carter's Volatility Breakout
📈 NO SQUEEZE - BULLISH MOMENTUM: No squeeze currently (bands expanded). Momentum is positive and rising (3.44) - bullish continuation likely. Watch for momentum to strengthen for confirmation.
Elder Ray (Bull/Bear Power)
Dr. Alexander Elder's Power Index
🚀 Strong bullish pressure - both bulls and bears above their normal ranges, bulls in control.
Force Index
Dr. Alexander Elder's Volume-Price Momentum
📊 Force Index shows bulls with slight edge. Short-term: 21.80M, Medium-term: 16.15M. Volume is normal.
Williams Alligator
Trend Direction & Strength
🍽️ Alligator is EATING - strong bullish trend in progress! Lines properly ordered (Lips 138.06 > Teeth 132.11 > Jaw 126.36). Spread at 9.26%. Ride the trend with trailing stops!
Donchian Channels
Richard Donchian's Breakout System (20-period)
Price broke above the 20-day high of $153.13
🚀 BULLISH BREAKOUT! Price $152.81 broke above the 20-day high of $150.50. Moderate breakout strength. Donchian breakouts often signal the start of new trends - consider long entries with stops below the middle band ($136.23).
Supertrend
ATR-Based Trend Following
📈 UPTREND active for 4 days. Price $152.81 is 22.8% above Supertrend $124.44. Moderate trend strength. The Supertrend line serves as trailing support - consider taking partial profits.
Choppiness Index
Trend vs Range Detection (14-period)
📈 TRENDING MARKET (CHOP: 23.1). The market is in a clear trend with low choppiness. Choppiness is decreasing (2.9 points). 🔥 Very strong trend - momentum strategies work best. Trading advice: Use TREND FOLLOWING strategies (moving average crossovers, breakouts, momentum). Avoid mean reversion or ranging strategies.
Valuation Metrics
Relative value indicators
💡 PEG < 1 suggests undervalued relative to growth • EV/EBITDA accounts for debt
Historical Returns
Price performance across timeframes
📈 Insight: Strong recent momentum with positive year-to-date performance. Consider trailing stop to protect gains.
Seasonality Analysis
Market Comparison
Performance vs S&P 500
Dividend History
Past payments & growth
| Ex-Date | Amount |
|---|---|
| Dec 15, 2025Latest | $0.7900 |
| Sep 15, 2025 | $0.7900 |
| Jun 13, 2025 | $0.7900 |
| Mar 14, 2025 | $0.7900 |
| Dec 13, 2024 | $0.7700 |
| Sep 13, 2024 | $0.7700 |
| Jun 14, 2024 | $0.7700 |
| Mar 14, 2024 | $0.7700 |
Growth Metrics
Year-over-year performance
Growth rates calculated from trailing twelve months vs prior period
Analyst EPS Estimates
Consensus earnings projections
| Fiscal Year | Est. EPS | YoY Growth |
|---|---|---|
| FY26 | $8.59 | +31.4% |
| FY27 | $9.31 | +8.4% |
| FY28 | $9.60 | +3.1% |
Based on analyst consensus estimates. Actual results may vary.
Insider Activity
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Invalid Date | Unknown | SELL | 0 | $0K |
| Invalid Date | Unknown | SELL | 0 | $0K |
| Invalid Date | Unknown | SELL | 0 | $0K |
| Invalid Date | Unknown | SELL | 0 | $0K |
| Invalid Date | Unknown | SELL | 0 | $0K |
Recent News
Targeted Cancer Therapy Market to Reach US$ 175.48 Billion by 2035 Driven by Precision Oncology Adoption, ADC Innovation, and Regulatory Productivity Says Astute Analytica
This Top Non-Tech AI Trade for 2026 Pays a Huge 11.6% Dividend
Medicare Targets 15 High-Profile Drugs In Third Price Negotiation Cycle
Autologous Cell Therapy Market Size to Reach US$ 44.55 Billion by 2033 | Astute Analytica
4D Path Joins Phase II Clinical Trial to Advance Predictive Biomarkers in Bladder Cancer
Kymera Therapeutics Outlines Key 2026 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs
GSK/Ionis Partnered Investigational Drug Shows Strong Results In Large Hepatitis B Studies
3 Cash-Flow Machines Investors May Want Heading Into 2026
Repare Therapeutics Stock Rises As Gilead Secures Cancer Asset For $30 Million
3 Companies Turning Big Cash Flow Into Bigger Shareholder Gains
SEC Filings
💪 Strengths
- ✓Healthy profit margins (27.9%)
🚀 Opportunities
- →Market conditions could present buying opportunities
⚠️ Weaknesses
- !No significant weaknesses identified
🛑 Threats
- ✕Broader market volatility remains a risk
⚡ Catalysts
- ★Earnings releases and guidance updates
⚠️ Key Risks
- !Standard market and sector risks apply
Are you an AI agent?
Help improve this research! Submit corrections, updates, or suggestions via Moltbook.
AI Agent Feedback
Are you an AI agent? Help improve this analysis!